BRK-B vs CLM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CLM presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but not strong financial health. While the stock is significantly undervalued relative to its Graham Number ($12.85) and Intrinsic Value ($32.16), this value is offset by a critical dividend payout ratio of 134.12%, suggesting the current yield is unsustainable. Despite strong historical 1-year and 3-year price appreciation, the current technical trend is completely bearish (0/100), and the low current ratio (0.58) indicates potential liquidity constraints.
Compare Another Pair
Related Comparisons
BRK-B vs CLM: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Cornerstone Strategic Investment Fund, Inc. (CLM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.